[1]
Castañeda-Alarcón, M. et al. 2024. Comparative evaluation of dissolution profiles of the generic drug lamivudine 150 mg tablet marketed in Peru vs. the innovative Epivir. Revista Peruana de Medicina Experimental y Salud Pública. 41, 1 (Mar. 2024), 69–75. DOI:https://doi.org/10.17843/rpmesp.2024.411.12821.